New Insight into the Molecular Drug Target of Diabetic Nephropathy
Figure 2
Current drug targets in diabetic nephropathy. Interrelated derangements in cellular hemodynamic, metabolic, oxidative stress, inflammation; lipid dysfunction, and extracellular matrix accumulation occur in diabetes and lead to diabetic nephropathy. These derangements provide the targets for the development of mechanism based drugs.
